are Virginia Murchison Linthicum Scholars in Medical Research at UTSW
Dose-response studies indicate that BPC-157 at 800 ng/kg produces near-complete ulcer healing with thick granulation tissue formation, demonstrating potent effects at remarkably low doses
38 There is evidence that genetic variability or absence of OATP1B1/1B3 function, as seen in RS, can substantially increase plasma concentrations of drugs including statins, ezetimibe, angiotensin II receptor blockers, methotrexate, mycophenolic acid, cyclosporin A, rifampicin, thiazolidinediones, glinides, antiretrovirals, antihistamines, and several anticancer agents (Table 2)
Research has shown KPV: Reduces intestinal inflammation Supports gut barrier function Modulates the immune response in inflammatory bowel conditions For long COVID patients with significant gut dysfunction and gut-driven systemic inflammation, KPV offers a targeted, well-tolerated option for reducing the gut-immune inflammatory burden
Mutation research
A serum containing 15% L-ascorbic acid combined with ferulic acid offers enhanced skin absorption and targeted benefits